Jian Shen Selected Research

Depressed Skull Fracture

3/2022

A simple and successful treatment for rupture and defect of the posterior third superior sagittal sinus caused by open depressed skull fracture: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Shen Research Topics

Disease

124	Neoplasms (Cancer) 05/2022 - 03/2002
34	Inflammation (Inflammations) 05/2022 - 08/2007
22	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2014
17	Neoplasm Metastasis (Metastasis) 10/2021 - 11/2009
15	Hemolysis 02/2020 - 10/2008
14	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2010
14	Carcinoma (Carcinomatosis) 07/2019 - 02/2002
13	Insulin Resistance 01/2022 - 03/2009
13	Thrombosis (Thrombus) 10/2021 - 06/2004
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2010
12	Hemorrhage 12/2021 - 01/2013
12	Body Weight (Weight, Body) 01/2020 - 03/2005
11	Wounds and Injuries (Trauma) 01/2022 - 04/2011
11	Hypoxia (Hypoxemia) 01/2022 - 01/2012
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2016 - 08/2007
10	Infections 05/2022 - 09/2010
10	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 05/2008
10	Carcinogenesis 01/2020 - 03/2002
9	Stomach Neoplasms (Stomach Cancer) 11/2022 - 06/2011
9	Esophageal Squamous Cell Carcinoma 01/2017 - 01/2011
8	Ischemia 01/2022 - 07/2010
7	ST Elevation Myocardial Infarction 01/2022 - 03/2015
7	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2015
7	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 08/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2012
6	Heart Failure 01/2022 - 01/2016
6	Type 2 Diabetes Mellitus (MODY) 12/2021 - 03/2009
6	Hyperplasia 10/2021 - 04/2002
6	Stroke (Strokes) 08/2019 - 05/2008
6	Obesity 01/2018 - 08/2008
5	Hypertension (High Blood Pressure) 06/2022 - 05/2010
5	Reperfusion Injury 01/2022 - 07/2010
5	Fibrosis (Cirrhosis) 01/2022 - 01/2017
5	Pathologic Constriction (Stenosis) 01/2022 - 01/2015
5	Spinal Tuberculosis (Pott's Disease) 08/2021 - 06/2013
5	Adenocarcinoma of Lung 07/2021 - 09/2013
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2021 - 07/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 06/2020 - 09/2012
5	Cerebral Infarction 08/2017 - 05/2008
4	Glioblastoma (Glioblastoma Multiforme) 06/2022 - 07/2020
4	COVID-19 05/2022 - 12/2020
4	Bacterial Infections (Bacterial Infection) 01/2022 - 11/2019
4	Neuroinflammatory Diseases 01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2003
26	Pharmaceutical PreparationsIBA 04/2021 - 03/2010
19	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2008
13	Long Noncoding RNAIBA 01/2022 - 09/2013
13	CytokinesIBA 05/2021 - 11/2007
10	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2013
10	Arsenic Trioxide (Trisenox)FDA Link 12/2018 - 02/2002
9	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2008
9	Biological ProductsIBA 01/2022 - 09/2003
9	LipidsIBA 05/2021 - 05/2008
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2003
8	Messenger RNA (mRNA)IBA 01/2021 - 06/2011
7	CarbonIBA 01/2022 - 05/2019
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 06/2014
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2009
7	AntigensIBA 01/2022 - 02/2014
7	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021 - 01/2018
6	Therapeutic UsesIBA 05/2022 - 12/2013
6	methylallyl trisulfide (MATS)IBA 01/2022 - 09/2015
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 02/2002
6	CollagenIBA 01/2022 - 09/2017
6	SmokeIBA 06/2020 - 08/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2009
5	PlatinumIBA 01/2022 - 01/2015
5	HydrogelsIBA 01/2022 - 11/2020
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2011
5	Insulin (Novolin)FDA Link 12/2021 - 01/2013
5	AlbuminsIBA 12/2021 - 04/2017
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2008
5	AnticoagulantsIBA 01/2020 - 01/2013
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2013 - 08/2007
5	AgarIBA 06/2006 - 03/2002
4	CalciumIBA 05/2022 - 02/2002
4	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020
4	CateninsIBA 01/2022 - 05/2014
4	C-Reactive ProteinIBA 01/2022 - 05/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2013
4	EnzymesIBA 01/2022 - 01/2012
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2020
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 07/2012
4	fibrin fragment D (D-dimer)IBA 04/2021 - 07/2019
4	InterleukinsIBA 03/2021 - 01/2017

Therapy/Procedure

59	Therapeutics 11/2022 - 01/2004
16	Drug Therapy (Chemotherapy) 11/2022 - 01/2013
10	Neoadjuvant Therapy 01/2022 - 10/2012
8	Photochemotherapy (Photodynamic Therapy) 01/2022 - 10/2012
7	Photothermal Therapy 01/2022 - 01/2018
6	Percutaneous Coronary Intervention 01/2022 - 03/2015
6	Immunotherapy 01/2022 - 01/2020
6	Stents 12/2020 - 10/2013
5	Transplantation 05/2022 - 08/2002
5	Lasers (Laser) 03/2022 - 10/2016
5	Transjugular Intrahepatic Portasystemic Shunt 12/2021 - 01/2020
4	Ligation 03/2022 - 04/2016
4	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2021 - 12/2020
4	Punctures 01/2021 - 06/2013